Clinical Trials Directory

Trials / Suspended

SuspendedNCT02480595

AAA Registry: Clinical Outcomes of Highly Angulated anatomY Treated With the Aorfix™ Stent Graft

ARCHYTAS: AAA Registry: Clinical Outcomes of Highly Angulated anatomY Treated With the Aorfix™ Stent Graft

Status
Suspended
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Lombard Medical · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The ARCHYTAS Registry is a long-term, global, multicenter, non-randomized, prospective, registry designed to collect "on-label" data in real world clinical settings on patients undergoing endovascular repair with the latest generation Aorfix™ AAA Flexible Stent Graft System. Registry data will augment existing data from ongoing and prospective Aorfix™ clinical trials for the purposes of publication, general product development and quality measures.

Detailed description

The ARCHYTAS Registry is a long-term, global, multicenter, non-randomized, prospective, registry established by Lombard Medical Ltd. (Lombard) to collect "on-label" data in real world clinical settings on patients undergoing endovascular repair with the latest generation Aorfix™ AAA Flexible Stent Graft System, for treatment of abdominal aortic and aorto-iliac aneurysms in anatomy where the aorta in the aneurysm neck is bent through an angle between 0° and 90°. This indication for Aorfix™ is approved in all territories where this Registry is being operated and this Registry does not seek to collect data on any use of the implant for which full commercial approval does not already exist. The ARCHYTAS Registry data will augment existing data from ongoing and prospective clinical trials with Aorfix™ for the purposes of publication, general product development and quality measures.

Conditions

Interventions

TypeNameDescription
DEVICEStent GraftEndovascular repair of abdominal aortic aneurysm (EVAR)

Timeline

Start date
2015-04-01
Primary completion
2022-04-01
Completion
2022-04-01
First posted
2015-06-24
Last updated
2021-11-01

Locations

37 sites across 6 countries: Czechia, Germany, Italy, New Zealand, Spain, United Kingdom

Source: ClinicalTrials.gov record NCT02480595. Inclusion in this directory is not an endorsement.